Member Info for Boyobach

Yes, stronger than yesterday:

https://invst.ly/13mu-m

As shopfronts go, Darth, it's not very well lit.

From latest GM Documents: 'The Board proposes this change of name [to Argent Biopharma] on the basis that it believes the proposed name more accurately reflects the future operations of the Company.'

The term Biopharma might be slightly more precise. However, the name Argent provides a very useful separation from the somewhat obscure MGC and its dismal performance since it was listed in the UK. Could that be a more likely reason for the name change?

Meanwhile, looking at the Malta premises on Google (it's marked in the Hal Far Industrial Estate, Birżebbuġa) I expected to see a large glasshouse on the roof (as per drawings in the Edison Report dated 10/7/2019 on the MGC website) but the satellite image appears to pre-date the installation. The site has a five star rating on Google by a chap who gives no reason, no photo and possibly clicked on it by mistake whilst adding other places in the area. You'd think this stunning facility, funded by shareholders, would be a star feature on the MGC website wouldn't you?

So many questions....

Excellent points from Pokerchips IMV.

If it's more disappointing than last year, Gioviano, then I agree.

Bearing in mind that I'm currently out and generally quite negative about OCDO, I'm trying to be moderate/balanced.

The gaps bother us both don't they?

Disappointing results: 450

Promising results: 600

Average results:: 525

https://invst.ly/13mfbw

Oil Price isn’t the problem here: BP is underperforming, particularly since May2nd last year.

https://invst.ly/13me5v (chart of BP against Brent and Shel over 5 years)

OP is well above 2019 levels, when BP was around 550 with Brent at $66 .

Ha! No kidding Darth?

But this is a prominent European pharmaceutical company isn't it?

The website contains very pretty family snaps but surprisingly does not include any of the 'new, large scale production facilities' in Malta or give contact details for sales, enquiries or its corporate HQ , which it says is in the UK - but isn't it in Australia (very prominent on the map) ?.

How many employees are there and what key research, sales and production activities are being undertaken?

After all, according to the website, MGC Pharma has built strong relationships to produce the most rigorous research and develop a high-quality clinical pipeline with the most qualified, passionate experts in the pharmaceutical industry....

Lots of superlatives but no names, quotes or details.

It's hard to believe it exists based on the lack of substance there. Speaking of which, I must have another drag.

Kalhussain: I guess a proposed name change is not significant enough to notify shareholders by RNS .

Yes Pokerchips - guidance issued seven months ago and presumably on track and baked into the sp?

Looking more closely at that weekly chart, the price has come under a bit of pressure over the last month, suggesting a nudge lower unless the results, along with prospects, are significantly stronger than expected: https://invst.ly/13ln61

Fourteen years from listing at 180? No divi but about 8% pA compounded capital gain? OK, I guess, if it continues. What were people thinking when they paid over £28? The explosive tech opportunity they were anticipating is probably past IMV.

Tightly coiled or just fully released?

It’s usually the case that faith takes an sp up and reality brings it back down.

Here’s a weekly tick chart of OCDO, with the main current opposing trends, red (pessimistic) and green (optimistic) plus the twelve month simple moving average in blue:

https://invst.ly/13ljeq

Next week’s results will need to contain a helluva surprise to knock this off track but green and red can’t both survive for much longer. One possible outcome is that the sp continues to level out and they both get broken.

With the FY results having narrowed the gap in SP that opened up in the autumn between Shel and BP, it's disappointing to see it widening again over the last seven trading days: https://invst.ly/13lh1m

It should be at 485 today if it were holding its own.

Cheers GfG: googling the article was a good trick! Also an interesting read.

I guess for a PI the merits of buybacks depend very much on the individual’s reasons for investing (gain or income) and the likely timespan they’ll hold the shares.

I like some volatility plus overall capital gain in the sp in order to profit from trading, earn a divi AND see an overall capital gain - I like to have my cake and eat it (several times over if possible).

However, I have to confess that my go-to argument to justify my point of view - a comparison of Shel & BP with the US companies that maintained their dividend is no longer as convincing as it once was, possibly because the divi is being restored AND debt has been reduced, whilst CVX have had a few issues of their own to resolve. Today, Shel and BP have overtaken CVX in the capital gain game from Oct 2020. Only XOM is now outrunning them all:

https://invst.ly/13kxmc

I’m not about to eat my hat or my words but I do have to accept that, over a long enough period of significant buybacks, some benefit may start to emerge - I still don’t like the fact that it can’t be measured, it doesn’t translate directly into £’s in my pocket and I don’t have as much control over how I maximise any gain I get from it. So you can still call ‘em ‘buyobacks’ to wind me up! ATB

Ha GfG! I couldn't read it without subscribing - but I'm guessing their view was positive to which my response would be:

'GofCompare Shel's sp to XOM and CVX since the nadir of October 2020 and also remember that the dividend cut has gone into buybacks rather than directly into yourfpocket' .

I was hoping to see the sp break above the red trend here yesterday:

https://invst.ly/13kkeg

Hopefully we'll see green prevail by the end of the month.

There doesn’t appear to have been an RNS here about the proposed name change to Argent BioPharma, as reported in businessofcannabis.com .

I dumped shares in this outfit a couple of years ago when I realised that information about it was very scant and unconvincing.

The website is superficial (check out the 'about us' section) with stock photos and no substantive detail about corporate addresses in UK, Australia, Malta, or elsewhere for that matter. No key qualified research staff are mentioned- it’s even less convincing than it was when I last checked it out and has all the features of a well presented scam. If the company is genuine then it's not surprising that it is failing.

Hanoi: I didn't say they did.

You also missed the obvious point of my post: The SFO matter is closed as far as PFC (and its subsidiaries) is concerned .

The ongoing saga of PFC’s historic involvement in corruption distracts attention from the fundamental performance of the company.

When the SFO’s case against PFC was concluded in 2021, shareholder expectations were that the company/s valuation would recover. However, this has not happened.

So how does PFC’s sp performance in the sector actually compare to, say, that of Halliburton ?

https://invst.ly/13iskg

The chart rebases PFC and HAL to immediately prior to conclusion of the case against PFC. Since then HAL has risen by around 70% and PFC has declined by around 70%.

It is not an encouraging indication.

A much longer term comparison of the two gives another perspective, which some might conclude links PFC’s golden years to the period of corruption and its decline to the consequential reputational damage and/or poor management:

https://invst.ly/13isma

Either way, it is difficult to be positive about PFC as it simply hasn't performed well as a business over the last seven years in this comparison with a peer.

What is the continuing problem and can it be fixed?

Yes geOrge123 - that's why I posted the quote.

The SFO matter is closed as far as PFC is concerned but not necessarily for individuals.

However, further news of action against individuals serves as an unfortunate reminder of PFC's involvement.

Petrofac Limited’s conviction and sentencing in October 2021 brought to a conclusion the SFO’s investigation as far as the corporate entity (and its subsidiaries) is concerned. The investigation into the conduct of individual suspects continues.

See last para of full archived SFO statement :

https://www.sfo.gov.uk/2021/10/04/serious-fraud-office-secures-third-set-of-petrofac-bribery-convictions/

I remain curious about another individual, previously associated with PFC in the UAE, who appears to have avoided prosecution so far. So I wouldn’t be surprised if there was further news on this subject in the future.

I wasn’t around to add a trading tranche during this afternoon’s dip below 2430: https://invst.ly/13htqg

I anticipate that the sp will return to fill the gap to 2566 over the next month or two provided OP continues at around $82 but I currently doubt that it’ll push much higher than that without a further increase in OP, as this comparison with Brent demonstrates: https://invst.ly/13h-oz

Ha! Ordinarily I'd agree about the seasonal pattern, Littleaston - just don't look at what happened last year, when we had to wait until September for January's OP highs to be surpassed: https://invst.ly/13eyh0

The sp also stayed below 2475 after March for much of the year until September and October.